JCIA
MRNA icon

Jackson Creek Investment Advisors’s Moderna MRNA Stock Holding History

Jackson Creek Investment Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,467
Closed -$292K – 347
2022
Q3 		$292K Sell
2,467
-660
-21% -$100K 0.14% 273
2022
Q2 		$513K Buy
+3,127
New +$447K 0.21% 227

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jackson Creek Investment Advisors's MRNA Position: Q4 2022 in Review

Jackson Creek Investment Advisors sold out of Moderna (MRNA) in Q4 2022, closing a stake of 2,467 shares — an estimated $292K sold.

Jackson Creek Investment Advisors first reported a position in MRNA in Q2 2022 and held it in 2 quarters. The position peaked at $513K in Q2 2022. 1,072 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Jackson Creek Investment Advisors reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 2,467 Moderna shares in Q4 2022, an estimated $292K.
  • Jackson Creek Investment Advisors first reported a position in Moderna in Q2 2022 and held it in 2 quarters.
  • Jackson Creek Investment Advisors's Moderna position peaked at $513K in Q2 2022.
  • 1,072 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Jackson Creek Investment Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.